The hypoxia-inducible factor (HIF) takes part in transcriptional activation of hypoxia-responsive genes such as vascular endothelial growth factor (VEGF), insulin-like growth factor, and inducible nitric oxide synthase. Since VEGF plays an important role in pathological angiogenesis such as tumor growth and ischemic diseases, the inhibition of VEGF inducer HIF is an attractive approach for the inhibition of pathological angiogenesis. Recently, we have reported that the introduction of boronic acid and a carborane moiety into phenoxyacetanilide induced a potent inhibitory effect on HIF-1α activation under hypoxic conditions. In the present study, to clarify the mechanism of action of carboranylphenoxyacetanilide GN26361 against HIF inhibition, we designed and synthesized molecular probes of GN26361 substituted with benzophenone to induce covalent binding with the target protein by UV (photoaffinity labeling) and an acetylenic moiety to conjugate with the greenfluorescent Alexa Fluor 488-azide by click reaction. In-gel fluorescent imaging of target protein bound with the probe was identified as heat shock protein 60 (HSP60). Moreover, direct binding in gel fluorescent imaging was observed by photoaffinity labeling and click reaction of the probe with recombinant HSP60. These results indicate that HSP60 is the target protein of GN26361 and might be a new molecular target for HIF inhibition.
INTRODUCTION
The hypoxia-inducible factor (HIF) is a basic helix-loop-helix heterodimeric transcription factor, composed of one of three subunits (HIF-1α, -2α, or -3α) and a HIF-1β subunit [1] [2] [3] . Under aerobic conditions, HIF-1α is rapidly degraded via a 26S proteasome-dependent pathway, whereas under hypoxic conditions, HIF-1α is stabilized and translocated into the nucleus where it dimerizes with the constitutively expressed HIF-1α [4] [5] [6] [7] . The HIF-1α/β dimer binds to specific nucleotide sequences (hypoxiaresponsive elements, HREs) in the promoter of hypoxia-responsive genes such as vascular endothelial growth factor (VEGF), insulin-like growth factor, heme oxygenase-1, and inducible nitric oxide synthase [8, 9] . Among the HIF-regulated genes, VEGF plays a pivotal role in pathological angiogenesis and tumor growth [10, 11] ; therefore, the inhibition of VEGF inducer HIF is recognized as an attractive strategy for cancer therapy [8, 12] . Our efforts have been focused on the development of HIF inhibitors [13] [14] [15] [16] [17] as anti-angiogenesis agents. Recently, we reported that carboranylphenoxyacetanilide GN26361 (1) induced a potent inhibitory effect on HIF-1α activation under hypoxic conditions [18] . In the present study, we clarified the action mechanism of 1 against HIF inhibition.
RESULTS AND DISCUSSION
Standard chemical biology techniques, including photoaffinity labeling, click conjugation, and biotinylation, are very useful tools for detecting target proteins of biologically active molecules having undefined action mechanisms [19] [20] [21] . Based on this approach, we designed and synthesized multifunctional molecular probes of 1 substituted with benzophenone to form covalent binding with a target protein by UV (photoaffinity labeling), and an acetylene moiety to conjugate with azide-linked fluorescence by click reaction (Fig. 1A) . The probes of 1 (2 and 3) were synthesized from 4-ethynylphenoxyacetic acid 5 and aminobenzophenones 6a-c (Scheme 1). To confirm whether the synthesized probes exhibit HIF inhibitory activity, we examined the effects of the probes on the hypoxia-induced activation of HIF in human cervical cancer cells HeLa by HRE reporter gene assay and immunoblot analysis. As shown in Figs. 1B,C, although the inhibitory effects of the probes against HIF transcriptional activity were decreased almost 10-fold compared with 1 (Fig. 1B) , the reducing property of the probes on the HIF-1α protein level was parallel to that of 1 (Fig. 1C) . These results support that boronic acid in 1 is an efficient functional group for HIF inhibition, a finding similar to the results of our previous study [18] .
Using these probes, we performed photoaffinity labeling in HeLa cell lysate and click conjugation with Alexa Fluor 488-azide to visualize the target protein. Following sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), proteins bound to the probe-Alexa Fluor 488 were visualized by direct in-gel fluorescence detection. As shown in Fig. 2A Identification of HSP60 as HIF-1α regulator 2327
Scheme 1 Synthesis of molecular probes 2 and 3. 55 kDa molecular weight marker was detected by both probes in a concentration-dependent manner, and binding of 3 with the protein was slightly more sensitive than that of 2. To confirm the specificity of probe binding, we performed competition assays with 1 or 8c, an acetylene-free analog of 2 and 3.
As shown in Fig. 2B , competition with 1 resulted in almost complete abrogation of the level of the fluorescent band at ~55 kDa. Furthermore, whole cell lysates from HeLa cells exposed to normoxic or hypoxic conditions (4 h) were preincubated with 8c, and then photoaffinity was labeled with 3. In both normoxic and hypoxic conditions, the band was decreased by the presence of 8c (Fig. 3D , lanes 3 and 6). These results raise the possibility that the band at ~55 kDa may be the main target protein of 1 and its probes.
To identify the protein manifest at above 55 kDa, we next performed two-dimensional electrophoresis followed by in-gel digestion and peptide mass fingerprinting analysis (PMF) by liquid chromatography/electrospray ionization time-of-flight mass spectrometry (LC/ESI-TOF MS) (Fig. 4) .
As shown in Table 1 , PMF analysis searched in Mascot revealed that the protein bound to the probe was heat shock protein (HSP) 60 with a significant score value of 245, sequence coverage of 73 %, and 28 peptides matching. To confirm the direct binding of 3 and HSP60, in-gel fluorescence imaging was performed with recombinant human HSP60 protein, and a fluorescent band was observed in the presence of 3 (Fig. 5A, lane 2) . Under these conditions, an excess of 1 suppressed the binding of HSP60 and 3 (Fig. 5A, lane 3) . In addition, 3 selectively bound to HSP60 in mixture of recombinant HSP60, 70, and 90 (Fig. 5B) . Moreover, the immunoprecipitation assay demonstrated that HSP60 interacts with HIF-1α in HeLa cells (Fig. 5C ). These results suggest that the binding of 1 to HSP60 appears to be implicated in the inhibition of HIF-1α. Identification of HSP60 as HIF-1α regulator 2329 To further clarify the relationship between HSP60 and HIF-1α, the effects of a known HSP60 inhibitor epolactaene tert-butyl ester (ETB) 4 [22] (Fig. 6A ) on the hypoxia-induced activation of HIF were examined. As shown in Fig. 6 , 4 inhibited the hypoxia-induced accumulation of HIF-1α similar to 1 (Fig. 6B ) and transcriptional activation of HIF with an IC 50 value of 1.9 μM (Fig. 6C) . Furthermore, 4 showed the competitive property against binding of 3 to recombinant HSP60 (Fig. 6D, lane 3) . These results indicate that HSP60 inhibitor 4 inhibits activation of HIF as well as 1, and support that HSP60 is involved in the activation of HIF-1α. Moreover, 1 inhibited HSP60 chaperone activity similar to 4 (Fig. 7A) . Interestingly, 1 suppressed HSP60 ATPase activity (Fig. 7B) , however, 4 did not affect.
It has been reported that HIF-1α is one of the client proteins of molecular chaperon HSP90, and geldanamycin, a HSP90 inhibitor that stimulates HIF-1α degradation by affecting folding and maturation [23] [24] [25] . Unlike HSP90, the interaction of HSP60 and HIF-1α has not been established. To our knowledge, this is the first report demonstrating the implication of HSP60 in HIF activation. However, details of the functional association between HSP60 and HIF-1α remain to be elucidated. 
CONCLUSION
We have succeeded in the design and synthesis of multifunctional molecular probes of HIF-1 inhibitor carboranylphenoxy acetanilide 1 for combining photoaffinity labeling and click reaction to identify the target protein. Identification of HSP60 as HIF-1α regulator 2331 HSP60 inhibitor 4 suppressed hypoxia-induced HIF activation, indicating that HSP60 might be a new molecular target for HIF inhibition.
EXPERIMENTAL

General information
1 H and 13 C NMR spectra were recorded on JEOL JNM-AL 300 (300 MHz) or VARIAN UNITY-INOVA 400 (400 MHz) spectrometers. The chemical shifts are reported in δ units relative to internal tetramethylsilane. IR spectra were recorded on a Shimadzu FTIR-8200A spectrometer. High-resolution mass spectra (ESI) were recorded on a Bruker Daltonics micro TOF-15 focus. Elemental analyses were performed by a CE instrument EA1110 CHNS-O automatic elemental analyzer. Analytical thin layer chromatography (TLC) was performed on glass plates of silica gel 60 GF 254 (Merck). Column chromatography was conducted on silica gel (Merck Kieselgel 70-230 mesh). Most commercially supplied chemicals were used without further purification.
Synthesis of chemical probes of 1
Synthesis of 2 and 3 is shown in Scheme 1. The carboxylic acid 5, which was prepared according to our reported procedure [18] , was reacted with the aminobenzophenones 6a (p-isomer) or 6b (m-isomer) using 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) and l-hydroxybenzotriazole (HOBt) to give the corresponding aryloxyacetanides 7a and 7b in 81 and 71 % yields, respectively. Diisopropylethylamine (DIPEA) was an effective base for these amide formations. Decaborane coupling reaction proceeded at the ethynyl moiety of compounds 7 in the presence of acetonitrile as a Lewis base under toluene reflux to give the corresponding carborane derivatives 8a and 8b in 65 and 45 % yields, respectively. Debenzylation of compounds 8 was carried out in the presence of Pd/C under hydrogen atmosphere, and the resulting phenols were treated with propargyl bromide under basic conditions to afford the m-probe 2 and p-probe 3 in 37 and 61 % yields, respectively.
N-[3-(4-Benzyloxybenzoyl)phenyl]-2-(4-ethynylphenoxy)acetamide (7a)
To a mixture of 4-ethynylphenoxyacetic acid 5 (0.123 g, 0.7 mmol), 3-aminobenzophenone 6a (0.19 g, 0.63 mmol), and DIPEA (0.12 mL, 0.7 mmol) in DMF (5.0 mL) were added EDCI (0.202 g, 1.0 mmol) and HOBT (0.142 g, 0.9 mmol), and the mixture was stirred overnight at room temperature. The mixture was then extracted with EtOAc, and the combined organic layer was washed with 1N HCl, neutralized with saturated aqueous NaHCO 3 , washed with brine, and dried over MgSO 4 . The solvent was evaporated, and the residue was purified by silica gel column chromatography with hexane/EtOAc (5/1) to provide 7a (0.238 g, 0.52 mmol, 81 %) as a white solid: 1 
N-(3-Benzoylphenyl)-2-(4-carboranylphenoxy)acetamide (8c)
This compound was prepared from 7c (70 mg, 0.2 mmol) and decaborane (29 mg, 0.24 mmol) and aceto nitrile (0.3 mL, 6 mmol) by the same procedure as described for compound 8c. 
2-(4-Carboranylphenoxy)-N-[3-(4-prop-2-ynyloxybenzoyl)phenyl]acetamide (2)
A suspension of 8a (0.165 g, 0.28 mmol) and 10 % Pd/C (0.1 g) in EtOAc (15 mL) was stirred at room temperature under H 2 . After 11 h, the mixture was filtered through a Celite bed and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography with hexane/EtOAc (3/1) to provide 9a (0.113 g, 0.23 mmol, 82 %) as a white solid: 1 1H) . To a mixture of 9a (0.042 g, 0.087 mmol), K 2 CO 3 (0.115 g, 0.83 mmol) in acetone (3 mL) was added propargyl bromide (10 μL, 0.13 mmol), and the mixture was refluxed overnight under argon. The precipitate in the reaction mixture was removed by filtration, and the solvent was evaporated. The residue was extracted with EtOAc twice, and the combined organic layer was washed with saturated aqueous NH 4 Cl and brine, and dried over MgSO 4 . The solvent was evaporated and the residue was purified by silica gel column chromatography with hexane/EtOAc (3/1) to provide 2 (0.017 g, 0.032 mmol, 37 %) as a white solid: 1 
2-(4-Carboranylphenoxy)-N-[3-(3-prop-2-ynyloxybenzoyl)phenyl]acetamide (3)
Cell culture
The human cervical carcinoma cell line HeLa cells were obtained from the Cell Resource Center for Biomedical Research, Institute of Development, Aging and Cancer, Tohoku University (Sendai, Japan). The cells were cultured at 37 °C under 5 % CO 2 atmosphere in RPMI 1640 medium (Wako Pure Chemicals, Osaka, Japan) supplemented with 10 % fetal bovine serum (FBS, HyClone, Logan, UT), 100 U/ml penicillin, and 100 μg/ml streptomycin (Invitrogen, Carlsbad, CA). For subsequent experiments, the cells were seeded at a density of 2 × 10 5 cells/ml/well in a 12-well TC plate (Greiner Japan, Tokyo, Japan), and incubated at 37 °C for 20 h. 
Two-dimensional electrophoresis and proteomics
The dehydration of IPG strips (Immobiline DryStrip, pH 3-10, 7 cm, GE Healthcare) were performed for 12 h in dehydration buffer (8 M urea, 2 % CHAPS, 18 mM DTT, 2 % IPG buffer (GE Healthcare), and 50 μg/ml bromophenol blue) containing the probe-labeled protein. Isoelectric focusing was carried out as follows; 300 V for 4 h, 1000 V for 30 min, 5000 V for 80 min, and 5000 V for 25 min using the Ettan IPGphor 3 (GE Healthcare). The IPG strips were incubated for 15 min in equilibration buffer I (50 mM Tris-HCl, pH 8.8 containing 2 % SDS, 6 M urea, 30 % glycerol, and 1 % DTT) followed by equilibration buffer II (2% SDS, 6 M urea, 30 % glycerol, and 2.5 % iodoacetamide in 50 mM TrisHCl, pH 8.8) for 15 min. The strips were then transferred to 12 % polyacrylamide gel, and electrophoresis was performed at 125 V. After visualization of Alexa Fluor 488 fluorescence, the gel was stained with coomassie brilliant blue (CBB). The Alexa Fluor 488 fluorescence-visualized and CBB-stained spots were excised from the gel, reduced with 10 mM DTT, alkylated with 55 mM iodoacetamide, and trypsinized for 8 h at 37 °C. The digested peptide fragments were analyzed by LC/ESI-TOF MS system (Bruker Daltonics, Bremen, Germany), and the PMF was performed against SwissProt database using Mascot (<www.matrixscience.com>).
MDH refolding assay
The chaperone activity of HSP60 was determined using malate dehydrogenase from porcine heart (MDH, Sigma) [22] . Denaturation of MDH (17.1 μM) was performed for 2 h at 25 °C in 10 mM HCl. A mixture of HSP60 (4 μM) and HSP10 (8 μM, Assay Designs) was incubated for 90 min at 30 °C with or without 1 or 4 in reconstitution buffer [50 mM Tris, pH 7.6, 300 mM NaCl, 20 mM KCl, 20 mM Mg(CH 3 COO) 2 and 4 mM ATP]. The MDH folding reaction was performed in folding assay buffer (100 mM Tris, pH 7.6, 7 mM KCl, 7 mM MgCl 2 , 10 mM DTT, and 2 mM ATP) and final concentrations of MDH, HSP60, and HSP10 were 1.71, 1, and 2 μM, respectively. After incubation for 30 min at 42 °C, aggregation of MDH was measured as the level of turbidity at 340 nm.
HSP60 ATPase assay
The human recombinant HSP60 (1 μM) was incubated for 30 min at 25 °C with or without various concentration of 1 in assay buffer (50 mM Tris, pH 7.6, 7 mM KCl, and 7 mM MgCl 2 ), and then treated with ATP (1 μM). After incubation for 30 min at 37 °C, ATP content was determined by luciferase/luciferin reaction (Promega).
